NOVEL PLASMA PROTEIN BIOMARKERS: A TIME-DEPENDENT PREDICTIVE MODEL FOR ALZHEIMER’S DISEASE

Abstract

The prediction of Alzheimer’s disease (AD) onset is crucial for the efficient disease and the management of its progression. While current diagnostic methods often rely on neuroimaging and cerebrospinal fluid (CSF) biomarkers, there is a growing need for less invasive and more accessible predictive tools.